These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 10762456)
21. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892 [TBL] [Abstract][Full Text] [Related]
23. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. Hörkkö S; Bird DA; Miller E; Itabe H; Leitinger N; Subbanagounder G; Berliner JA; Friedman P; Dennis EA; Curtiss LK; Palinski W; Witztum JL J Clin Invest; 1999 Jan; 103(1):117-28. PubMed ID: 9884341 [TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. Hörkkö S; Miller E; Dudl E; Reaven P; Curtiss LK; Zvaifler NJ; Terkeltaub R; Pierangeli SS; Branch DW; Palinski W; Witztum JL J Clin Invest; 1996 Aug; 98(3):815-25. PubMed ID: 8698874 [TBL] [Abstract][Full Text] [Related]
25. The antibody repertoire of early human B cells. I. High frequency of autoreactivity and polyreactivity. Lydyard PM; Quartey-Papafio R; Bröker B; Mackenzie L; Jouquan J; Blaschek MA; Steele J; Petrou M; Collins P; Isenberg D Scand J Immunol; 1990 Jan; 31(1):33-43. PubMed ID: 2154032 [TBL] [Abstract][Full Text] [Related]
26. Expression of the Fabs of human auto-antibodies in Escherichia coli: optimization and determination of their fine binding characteristics and cross-reactivity. Kumar S; Kalsi J; Latchman DS; Pearl LH; Isenberg DA J Mol Biol; 2001 May; 308(3):527-39. PubMed ID: 11327785 [TBL] [Abstract][Full Text] [Related]
27. Anti-beta 2 glycoprotein I antibodies in centenarians. Meroni PL; Mari D; Monti D; Coppola R; Capri M; Salvioli S; Tincani A; Gerli R; Franceschi C Exp Gerontol; 2004 Oct; 39(10):1459-65. PubMed ID: 15501015 [TBL] [Abstract][Full Text] [Related]
28. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells. Howard DR; Eaves AC; Takei F Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of anti-cardiolipin antibody and its cross-reactivity in sera of patients with lepromatous leprosy. Furukawa F; Kashihara M; Imamura S; Ohshio G; Hamashima Y Arch Dermatol Res; 1986; 278(4):317-9. PubMed ID: 3740940 [TBL] [Abstract][Full Text] [Related]
30. Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction. Mustafa A; Nityanand S; Berglund L; Lithell H; Lefvert AK Circulation; 2000 Nov; 102(21):2576-81. PubMed ID: 11085959 [TBL] [Abstract][Full Text] [Related]
31. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies. Sherer Y; Tenenbaum A; Praprotnik S; Shemesh J; Blank M; Fisman EZ; Harats D; George J; Levy Y; Peter JB; Motro M; Shoenfeld Y Cardiology; 2001; 95(1):20-4. PubMed ID: 11385187 [TBL] [Abstract][Full Text] [Related]
32. Antibodies against monocytes and endothelial cells in the sera of patients with atherosclerotic peripheral arterial disease. D'Anastasio C; Impallomeni M; McPherson GA; Clements WG; Howells GL; Brooks PA; Batchelor JR Atherosclerosis; 1988 Nov; 74(1-2):99-105. PubMed ID: 3265060 [TBL] [Abstract][Full Text] [Related]
33. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies. Virella G; Koskinen S; Krings G; Onorato JM; Thorpe SR; Lopes-Virella M Clin Immunol; 2000 May; 95(2):135-44. PubMed ID: 10779407 [TBL] [Abstract][Full Text] [Related]
34. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications. Ahmed E; Nityanand S; Mustafa A; Brismar K; Lefvert AK Clin Exp Immunol; 1999 Feb; 115(2):255-9. PubMed ID: 9933450 [TBL] [Abstract][Full Text] [Related]
35. Human polyreactive IgM monoclonal antibodies with blocking activity against self-reactive IgG. Melero J; Tarragó D; Núñez-Roldán A; Sánchez B Scand J Immunol; 1997 Apr; 45(4):393-400. PubMed ID: 9105427 [TBL] [Abstract][Full Text] [Related]
36. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. Alam SM; McAdams M; Boren D; Rak M; Scearce RM; Gao F; Camacho ZT; Gewirth D; Kelsoe G; Chen P; Haynes BF J Immunol; 2007 Apr; 178(7):4424-35. PubMed ID: 17372000 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal anti-IgG autoantibodies derived from lipopolysaccharide-activated spleen cells of 129/Sv mice. Van Snick JL; Coulie P J Exp Med; 1982 Jan; 155(1):219-30. PubMed ID: 6976413 [TBL] [Abstract][Full Text] [Related]